Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 1 | 1 | 3 | 3 |
Avg. Estimate | -0.31 | 0.37 | 2.65 | 4.03 |
Low estimate | -0.31 | 0.37 | 1.4 | 2.01 |
High estimate | -0.31 | 0.37 | 4.61 | 7.11 |
Year ago EPS | -0.59 | 0.35 | 0.55 | 2.65 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 1 | 1 | 3 | 3 |
Avg. Estimate | 4.25B | 7.54B | 31.14B | 34.7B |
Low estimate | 4.25B | 7.54B | 29.54B | 31.89B |
High estimate | 4.25B | 7.54B | 32.11B | 36.59B |
Year ago sales | 4.44B | 6.35B | 26.96B | 31.14B |
Sales growth (year/est) | -4.30% | 18.70% | 15.50% | 11.40% |
Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
---|---|---|---|---|
Est. EPS | -0.49 | 0.59 | 0.84 | 2.06 |
Actual EPS | -0.59 | 0.35 | 0.2 | 0.54 |
Difference | -0.1 | -0.24 | -0.64 | -1.52 |
Surprise % | -20.40% | -40.70% | -76.20% | -73.80% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | -0.31 | 0.37 | 2.65 | 4.03 |
7 days ago | -0.33 | 0.39 | 2.69 | 4.09 |
30 days ago | -0.35 | 0.38 | 2.62 | 3.98 |
60 days ago | 0 | 0 | 3 | 4.32 |
90 days ago | 0 | 0 | 2.99 | 4.32 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | 1 | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | EMBR3.SA | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 47.50% | N/A | N/A | N/A |
Next qtr. | 5.70% | N/A | N/A | N/A |
Current year | 381.80% | N/A | N/A | N/A |
Next year | 52.10% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | -2.59% | N/A | N/A | N/A |